DuoDERM Extra Thin

SECTION 2: Hazards identification

NFPA Rating Document Classification of the substance or mixture The product is not classified according to the Globally Harmonized System (GHS) Classification according to Directive 67/548/EEC or Directive 1999/45/EC Not applicable Information concerning particular hazards for human and environment: Not applicable Additional information USA According to 29CFR1910.1200(b)6(vii) for "Any drug, as that term is defined in the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 301 et seq.), when it is in solid, final form for direct administration to the patient (e.g., tablets or pills); drugs which are packaged by the chemical manufacturer for sale to consumers in a retail establishment (e.g., over-the-counter drugs); and drugs intended for personal consumption by employees while in the workplace (e.g., first aid supplies); 29CFR1910.1200 is not applicable CANADA

2.2 Label elements

Not applicable

Hazard pictograms

Not applicable

Signal word

Not applicable

Hazard statements

Not applicable

Additional information

USA: According to 29CFR1910.1200(b)6(vii) for "Any drug, as that term is defined in the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 301 et seq.), when it is in solid, final form for direct administration to the patient (e.g., tablets or pills); drugs which are packaged by the chemical manufacturer for sale to consumers in a retail establishment (e.g., over-the-counter drugs); and drugs intended for personal consumption by employees while in the workplace (e.g., first aid supplies); 29CFR1910.1200 is not applicable. CANADA

Classification system

NFPA ratings (scale 0 - 4) Health = 0 Fire = 0 Reactivity = 0 HMIS ratings (scale 0 - 4) Health = 0 CR-020618 Fire = 0 Reactivity = 0 per approved

2.1 Classification of the substance or mixture

Classification according to Directive 67/548/EEC or Directive 1999/45/EC Not applicable. Information concerning particular hazards for human and environment: Not applicable. Additional information: USA: According to 29CFR1910.1200(b)6(vii) for "Any drug, as that term is defined in the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 301 et seq.), when it is in solid, final form for direct administration to the patient (e.g., tablets or pills); drugs which are packaged by the chemical manufacturer for sale to consumers in a retail establishment (e.g., over-the-counter drugs); and drugs intended for personal consumption by employees while in the workplace (e.g., first aid supplies); 29CFR1910.1200 is not applicable. CANADA: Medical devices within the meaning of the FOOD AND DRUGS ACT (R.S.C., 1985, c. F-27) are not subject to the WHMIS supplier label and MSDS requirements of the Hazard Products Act.